Development of cell adhesion molecule antagonists as therapeutics for asthma and COPD
Authors:
- Peter VanderslicePVPeter Vanderslice
- Ronald J BiedigerRBRonald J Biediger
- Darren G WoodsideDWDarren G Woodside
- Kurt L BerensKBKurt L Berens
- George W HollandGHGeorge W Holland
- Richard A.F DixonRDRichard A.F Dixon
- 1 February 2004
- journal article
- review article
- Published by Elsevier in Pulmonary Pharmacology & Therapeutics
- Vol. 17 (1) , 1-10
Abstract
No abstract availableKeywords
This publication has 92 references indexed in Scilit:
- IntegrinsCell, 2002
- The Pathophysiology of AsthmaAnnual Review of Medicine, 2002
- Recombinant soluble P-selectin glycoprotein ligand-1 protects against myocardial ischemic reperfusion injury in catsCardiovascular Research, 1999
- αdβ2 Integrin Is Expressed on Human Eosinophils and Functions as an Alternative Ligand for Vascular Cell Adhesion Molecule 1 (VCAM-1)Journal of Experimental Medicine, 1998
- Neutrophil Emigration in the Skin, Lungs, and Peritoneum: Different Requirements for CD11/CD18 Revealed by CD18-deficient MiceJournal of Experimental Medicine, 1997
- Ligand-specificity of the selectinsJournal of Cellular Biochemistry, 1996
- Individually Distinct Ig Homology Domains in PECAM-1 Regulate Homophilic Binding and Modulate Receptor AffinityJournal of Biological Chemistry, 1996
- Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigmCell, 1994
- Signaling by vascular cell adhesion molecule‐1 (VCAM‐1) through VLA‐4 promotes CD3‐dependent T cell proliferationEuropean Journal of Immunology, 1991
- Endothelial leukocyte adhesion molecule-1 mediates antigen-induced acute airway inflammation and late-phase airway obstruction in monkeys.Journal of Clinical Investigation, 1991